Navigation Links
Advertisements for Medical Devices, Implants Should Carry Warnings of Dangerous Side Effects, Infections
Date:12/17/2007

Consumers Union Petitions FDA to Require Clearer Warnings on DTC Device Ads

WASHINGTON, Dec. 17 /PRNewswire-USNewswire/ -- Consumers Union has filed a petition with the FDA requesting it require all advertisements for implantable devices -- such as knee, hip and heart valve replacements, cosmetic implants and heart stents -- carry a warning about the possibility of dangerous infections or failures of the devices once they are in the body.

Implantable device makers recently have launched a wave of direct-to-consumer advertisements for their products, and Consumers Union said a review of these ads show that most lack basic information about the possibility of severe or fatal side effects.

"There is no question that many of these devices can restore high quality-of-life in patients, but we are concerned that serious and possibly deadly side effects like infections are consistently understated in these device ads," said Bill Vaughan, senior policy analyst for Consumers Union, publisher of Consumer Reports.

"We're asking the FDA to require clear warnings about the dangers of infection during and following such surgery, and information about how long the devices are likely to last once they are in the body," Vaughan said.

To read the full petition to the FDA, go to http://www.ConsumersUnion.org.

In light of the rising rate of MRSA and other hospital-acquired infections for surgical patients, CU is requesting device advertisements disclose the potential risk of infection and urge patients to ask their doctor and hospital about infection rates at the facility where the surgery will be performed. Nearly 100,000 people die each year from hospital-acquired infections, and CU is supporting national infection-reporting and prevention legislation (HR 1174, HR 4214 and S 2278).

The Centers for Disease Control infection surveillance report shows hip and knee prosthesis surgery to be a serious source of infection, in some cases a high-risk source, and in some of the reporting hospitals, the infection rate may run as high as 5 percent or more.

Another recent study of 2003 nationwide data for primary total, partial, and revision hip replacements found the rates of readmission for any cause within 90 days of surgery ran between 9 percent for total replacement to 21 percent for partial.

"We do not want to discourage those in pain and facing loss of mobility from seeking out medical advice on implants. But we do believe that unintended side effects, which can include death, can be minimized if the public is better educated to avoid facilities which are not practicing the highest level of anti-infection practices," Vaughan said.

"Placing information about the danger of infection from surgery in device advertisements will speed the day that America's surgical centers and hospitals address this life-and-death problem," he added.


'/>"/>
SOURCE Consumers Union
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Meth Project Advertisements Selected for National Prevention Campaign
2. MSU engineering team designs innovative medical device
3. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
4. Providence St. Joseph Medical Center, Caregivers Reach Agreement on a Union Contract
5. Owner and Operator of Florida Durable Medical Equipment Company Convicted of Medicare Fraud
6. Father and Daughter From Tanzania Receive Their First Medical Examination in Newport Beach
7. Doctors and medical ethicist discuss whether doctors should participate in capital punishment
8. Preparation for Natural Disasters Critical for People With Diabetes, Chronic Medical Conditions
9. Doctors and Medical Ethicist Discuss Whether Doctors Should Participate in Capital Punishment
10. Symmetry Medical Completes Acquisition Of Specialty Surgical Instruments
11. Milestone Scientific Announces Successful Completion of its Collaboration Agreement With Carticept Medical
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... (PRWEB) , ... April 24, 2017 , ... ... countries clearly shows that over the last decade, student well-being has seriously declined. ... the boxes of formal education, join the Islamic State to turn the historic ...
(Date:4/24/2017)... ... 24, 2017 , ... “Learning to Use Your SPIRITUAL COMPASS To Navigate Life ... Your SPIRITUAL COMPASS To Navigate Life Issues” is the creation of published author, Rachel ... Board of Directors for CONTACT USA, and former member of the American Association of ...
(Date:4/24/2017)... Miami, FL (PRWEB) , ... April 24, 2017 ... ... John Paul Gallardo, DDS, PA will be attending the 2017 Oral Reconstruction Foundation’s ... 4-6, 2017. , The Oral Reconstruction Foundation will present its annual Global Symposium ...
(Date:4/24/2017)... (PRWEB) , ... April 24, 2017 , ... ... lifestyle brands, work wear distributors and International relief organizations across the globe to ... company also offers lifestyle and work wear collections via insectshield.com . In ...
(Date:4/24/2017)... (PRWEB) , ... April 24, 2017 , ... ... and laboratory-grade deionized water from the same place. From 101 Water Texas, here ... Satisfaction: Patients and staff can enjoy a continuous supply of pure, fresh, oxygenated ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... 2017 Cardiology devices segment is anticipated to reach ... The Cardiology Devices segment is likely to create absolute $ ... 2018 over 2017. By the end of 2027, Cardiology Devices ... US$ 700 Mn, expanding at a CAGR of 18.4% over ... Asia Pacific reprocessed medical devices market in ...
(Date:4/19/2017)... VIEW, Calif. , April 19, 2017  IRIDEX ... it will release financial results for the first quarter ... 3, 2017.  The Company,s management team will host a ... 5:30 p.m. ET. Investors interested in listening ... (844) 707-0665 for domestic callers or (703) 326-3030 for ...
(Date:4/19/2017)... 2017 Global Prostate Cancer Therapeutics Market: ... prostate cancer therapeutics market analyzes the current and ... of prostate cancer, launch of promising emerging therapies, ... new drugs & therapeutic biological products, and high ... lesser side effects are some of the drivers ...
Breaking Medicine Technology: